EDT, a tetrahydroacridine derivative inhibits cerebral ischemia and protects rat cortical neurons against glutamate-induced cytotoxicity

Acta Pharmacologica Sinica

Volumn 24, Issue 5, 2003, Pages 390-393+477

  Sheng, Rui ^a,b   Liu, Guo Qing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

Author keywords

9 (4 ethoxycarbonylyphenoxy) 6,7 dimethoxy 1,2,3,4 tetrahydroacridine (EDT); Brain ischemia; Cell culture; Glutamic acid; Neurons; Nitric oxide; Tetrahydroacridines

Indexed keywords

9 (4 ETHOXYCARBONYLPHENOXY) 6,7 DIMETHOXY 1,2,3,4 TETRAHYDROACRIDINE; GLUTAMATE RECEPTOR; GLUTAMIC ACID; LACTATE DEHYDROGENASE; NIMODIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; TACRINE DERIVATIVE; TRIPHENYLTETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CELL; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL CULTURE; CELL SURVIVAL; COLORIMETRY; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; FEMALE; MALE; MEASUREMENT; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROLOGIC DISEASE; NEWBORN; NONHUMAN;

ACRIDINES; ANIMALS; BRAIN ISCHEMIA; CELL DIVISION; CELLS, CULTURED; FEMALE; GLUTAMIC ACID; INFARCTION, MIDDLE CEREBRAL ARTERY; L-LACTATE DEHYDROGENASE; MALE; MICE; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITROPRUSSIDE; RANDOM ALLOCATION; RATS; RATS, WISTAR;

EID: 0037693993     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Hademenos GS, Massoud TF. Biophysical mechanisms of stroke. Stroke 1997; 28: 2067-77.
2. Dyker AG, Lees KR. Duration of neuroprotective treatment for ischemic stroke. Stroke 1998; 29: 535-42.
3. Zhou JP, Zhang HB, Huang WL. Synthesis and biological activities of tetrahydroacridine derivatives. Chin J Med Chem 2000; 10: 172-6.
4. Sheng R, Liu GQ. Protective effects of 9-(4-ethoxycarbonylyphenoxy)-6,7-dimethoxy-1,2,3,4-tetrahydroacridine on anoxia and ischemic injury in cultured PC12 cells. Chin J Clin Pharmacol Ther 2001; 6: 330-3.
5. Sheng R, Liu GQ. Effects of 9-(4-ethoxycarbonylyphenoxy)-6,7-dimethoxy-1,2,3,4-tetrahydroacridine on learning and memory ability in mice. Chin J Clin Pharmacol Ther 2002; 7: 14-7.
6. Berderson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of neurologic examination. Stroke 1986; 17: 472-6.
7. Tamura A, Graham DI, McCuUoch J, Teasdale GM. Focal cerebral ischemia in the rat. I. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metabol 1981; 1: 53-60.
8. Liu JG, Gao C, Li R, Liu GQ. The protective effects of daurisoline on cerebral ischemia in mice and rats. Chin J Pharm Bull 1998; 14: 18-21.
9. Choi DW, Maulucci-Gedde MA, Kriegstein AR. Glutamate neurotoxicity in cortical cell culture. J Neurol Sci 1987; 7: 357-68.
10. Tamura Y, Sato Y, Yokota T, Akaike A, Sasa M, Takaori S. Ifenprodil prevents glutamate cytotoxicity via polyamine modulatory site of N-methyl-D-asperate receptors in cultured cortical neurons. J Pharmacol Exp Ther 1993; 265: 1017-25.
11. Wang YX, Sun J, Sun MJ. Prophylactic effect of methylene blue against neurotoxicity of sodium nitroprusside. Acta Pharmcol Sin 1999; 20: 185-7.
12. Zhang QZ, Zhao MR, Zhang JT. Effects of melatonin on nitric oxide content and its neurotoxicity in cerebral cortex. Acta Pharm Sin 1999, 34: 272-6.
13. McCulloch J. Excitatory amino acid antagonists and their potential for the treatment of ischemic brain damage in man. Br J Clin Pharmacol 1992; 34: 106-14.
14. Grotta J. The current status of neuronal protective therapy: why have all neuronal protective drugs worked in animals but none so far in stroke patients? Cerebrovasc Dis 1994; 4: 115-20.